Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Embryo Development Measure Depending on the DNA Sperm Fragmentation

NCT02214537 is registered in ClinicalTrials.gov with IVI Madrid as lead sponsor.

NCT NCT02214537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02214537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Embryo Development Measure Depending on the DNA Sperm Fragmentation
Lead sponsor
IVI Madrid
Phase
Not applicable
Overall status
Terminated
Start date
February 29, 2016
Completion date
February 28, 2018
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blastocyst time, cleavage times, embryo compaction, pronuclear appearance, pronuclear fading